The Impact of the COVID-19 Pandemic on Self-Reported Outcomes in Patients With Adrenal Insufficiency

Dingfeng Li,Malavika Suresh,Tiffany Abbondanza,Anand Vaidya,Irina Bancos
DOI: https://doi.org/10.1210/clinem/dgab334
2021-06-16
Abstract:Context: The COVID-19 pandemic has impacted healthcare environment. Objective: To determine the impact of the pandemic on self-reported outcomes in patients with adrenal insufficiency (AI). Design and setting: Prospective longitudinal survey study at 2 tertiary centers. Participants: Patients with AI. Intervention: Patient-centered questionnaire. Main outcome measures: Depression Anxiety Stress Scales-21, Short Form-36, and AI self-management. Results: Of 342 patients, 157 (46%) had primary AI, 109 (32%) had secondary AI, and 76 (22%) had glucocorticoid-induced AI. When compared to prepandemic, daily glucocorticoid dose and number of adrenal crises did not change. However, patients reported a higher financial impact from AI (34% vs 23%, P = 0.006) and difficulty accessing medical care (31% vs 7%, P < 0.0001) during the pandemic. A third of patients reported difficulty managing AI during the pandemic. After adjusting for duration and subtypes of AI, younger patients [odds ratio (OR) 2.3, CI 95% 1.3-4.1], women (OR 3.7, CI 95% 1.9-7.1), poor healthcare access(OR 4.2, CI 95% 2.3-7.7), lack of good insurance support (OR 2.8, CI 95% 1.3-5.9), and those with a higher financial impact (OR 2.3, CI 95% 1.3-4.3) reported greater difficulties managing AI. Patients were more likely to report a higher anxiety score (≥8) if they found managing AI challenging during the pandemic (OR 3.0, CI 95% 1.3-6.9), and had lower Physical Component Summary (OR 4.9, CI 95% 2.2-11.0) and Mental Component Summary (OR 4.1, CI 95% 1.8-9.5) scores prior to the pandemic. Conclusions: A third of patients with AI reported difficulties with management of AI during the pandemic, particularly in younger patients, women, and those with poor healthcare access.
What problem does this paper attempt to address?